RecruitingNCT07314892

Psychiatric Status and Symptom Severity in Graft-versus-Host Disease (GvHD).

Prospective Assessment of the Impact of Psychiatric Status on Clinical Symptom Severity in Patients With Graft-versus-Host Disease (GvHD).


Sponsor

Medical University of Gdansk

Enrollment

200 participants

Start Date

Apr 8, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This prospective observational study evaluates the association between psychiatric status, GvHD-related symptom severity, and health-related quality of life in patients with graft-versus-host disease. Standardized and validated assessment tools, including the Lee Symptom Scale, will be used to collect psychiatric, clinical, and demographic data.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at the mental health and psychological wellbeing of people who have graft-versus-host disease (GvHD) — a complication that can happen after a bone marrow or stem cell transplant, where the donated cells attack the recipient's body. **You may be eligible if...** - You are an adult with a confirmed diagnosis of graft-versus-host disease (GvHD) - You are currently receiving follow-up care at the Bone Marrow Transplantation Outpatient Clinic at UCK in Gdańsk, Poland **You may NOT be eligible if...** - You have severe psychiatric disorders that would prevent you from cooperating with the study - You are in the terminal stage of multi-organ failure - You decline to give informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Department of Hematology and Transplantology

Gdansk, Pomeranian Voivodeship, Poland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07314892


Related Trials